Back
Olin Corp. 10K Form
Sell
45
OLN
Olin Corp.
Last Price:
$20.43
Seasonality Move:
5.67%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-26 | 10Q | OLN/Olin Corp. Quarterly |
| 2023-10-27 | 10Q | OLN/Olin Corp. Quarterly |
| 2023-07-28 | 10Q | OLN/Olin Corp. Quarterly |
| 2023-04-28 | 10Q | OLN/Olin Corp. Quarterly |
| 2022-10-27 | 10Q | OLN/Olin Corp. Quarterly |
| 2022-07-29 | 10Q | OLN/Olin Corp. Quarterly |
Receive OLN News And Ratings
See the #1 stock for the next 7 days that we like better than OLN
OLN Financial Statistics
Sales & Book Value
| Annual Sales: | $6.5B |
|---|---|
| Cash Flow: | $-44.4M |
| Price / Cash Flow: | 31.02 |
| Annual Sales: | $17.20 |
| Price / Book: | 1.25 |
Profitability
| EPS (TTM): | 0.46370 |
|---|---|
| Net Income (TTM): | $52.2M |
| Gross Margin: | $768.1M |
| Return on Equity: | 2.57% |
| Return on Assets: | 0.69% |
Olin Corp. Earnings Forecast
Key Olin Corp. Financial Ratios
-
The Gross Profit Margin over the past 45 years for OLN is 11.74%.
-
The Selling, General & Administrative Expenses for OLN have been equal to 6.25% of Gross Profit Margin.
-
The Research & Development expenses have been 0.28% of Revenue.
-
The Interest Expense is 175.71% of Operating Income.
-
The Net Earning history of OLN is 1.61% of Total Revenues.
-
Per Share Earnings over the last 45 years have been positive in 20 years.
Olin Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Chemicals |
| Sector: | Materials |
| Current Symbol: | OLN |
| CUSIP: | 680665 |
| Website: | olin.com |
Debt
| Debt-to-Equity Ratio: | 1.68 |
|---|---|
| Current Ratio: | 1.56 |
| Quick Ratio: | 0.73 |
Price-to-Earnings
| Trailing P/E Ratio: | 23.6 |
|---|---|
| Forward P/E Ratio: | 25.58 |
OLN Technical Analysis vs Fundamental Analysis
Sell
45
Olin Corp. (OLN)
is a Sell
Is Olin Corp. a Buy or a Sell?
-
Olin Corp. stock is rated a SellThe current Olin Corp. [OLN] share price is $21.45. The Score for OLN is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.